(Millions of yen) Japanese GAAP Japanese  GAAP Presentation Recognition and  measurement IFRS Note IFRS Liabilities and net assets Equity and liabilities Net assets Equity Share capital ¥ 103,001 ¥ — ¥ — ¥ 103,001 Share capital Capital surplus 176,822 — — 176,822 Capital surplus Treasury shares (72,285) — — (72,285) Treasury shares Retained earnings 917,511 — (42,039) 875,473 N Retained earnings Accumulated other comprehensive income (64,960) 1,937 154,619 91,596 O Other components of equity Subscription rights to shares 1,937 (1,937) — — 1,174,606 Total equity attributable to owners of the parent Total net assets 1,062,026 — 112,580 1,174,606 Total equity Liabilities Liabilities Long-term liabilities Non-current liabilities — 4,869 — 4,869 P Trade and other payables Deferred tax liabilities 34,715 183 (19,628) 15,270 Q Deferred tax liabilities Accrued retirement benefits for employees 18,273 718 13,210 32,201 R Retirement benefit  liabilities — 1,133 758 1,891 S Provisions — 1,391 — 1,391 T Other financial liabilities Other 17,011 (6,869) — 10,142 U Other non-current liabilities Total long-term liabilities 70,000 1,425 (5,661) 65,765 Total non-current liabilities Current liabilities Current liabilities Notes and accounts  payable-trade 102,835 98,928 — 201,762 V Trade and other payables Accounts payable-other 87,718 (87,718) — — V Accrued expenses 94,373 (94,373) — — — 10,361 — 10,361 W Income tax payable — 40,509 7,580 48,089 X Provisions Accrued bonus for directors 89 (89) — — Allowance for sales rebates 4,386 (4,386) — — X — 1,369 — 1,369 y Other financial liabilities Other 24,136 33,973 5,210 63,319 Z Other current liabilities Total current liabilities 313,536 (1,425) 12,790 324,900 Total current liabilities Total liabilities 383,536 — 7,130 390,665 Total liabilities Total liabilities and net assets ¥1,445,561 ¥ — ¥119,710 ¥1,565,271 Total equity and liabilities Astellas Pharma Inc.  _ Annual Report 2014 160